Alert: Attox's 2-Hour Antibiotic Test Targets $10.5B AMR Market in 2026

from Signal Daily: Startup & VC Pulse · host Signal Daily News

[object Object]

Episode metadata supplied by the publisher feed · Published Mar 25, 2026

Embed this episode

Attribution link and audio player

What this episode covers

Attox's Bactolizer cuts antibiotic testing from days to 2 hours, disrupting a $10.5B diagnostic market. But the real shift isn't speed—discover why hospitals must choose sides now against superbugs.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Alert: Attox's 2-Hour Antibiotic Test Targets $10.5B AMR Market in 2026

0:00 3:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Signal Daily: Startup & VC Pulse?

This episode is 3 minutes long.

When was this Signal Daily: Startup & VC Pulse episode published?

This episode was published on March 25, 2026.

Can I download this Signal Daily: Startup & VC Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!